Increasingly , focus is developing within the UK regarding Tesamorelin as a potential therapy for metabolic complications. While still relatively recent, awareness of its potential benefits – particularly in managing the symptoms of HIV-related changes in body fat – is gaining. Specialists are investigating its suitability, and patient inquiri